MoonLake Immunotherapeutics (MLTX) shares gained 5.11% today (2023-12-15). Is it the right time to buy?

What’s happening at MoonLake Immunotherapeutics (NasdaqCM:MLTX)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 5.11% (or 2.95 points) to $60.65 from its previous close of $57.70. So is it the right moment to buy?
Read more: MoonLake Immunotherapeutics (MLTX) shares gained 5.11% today (2023-12-15). Is it the right time to buy?